###begin article-title 0
Auto-Ubiquitination-Induced Degradation of MALT1-API2 Prevents BCL10 Destabilization in t(11;18)(q21;q21)-Positive MALT Lymphoma
###end article-title 0
###begin p 1
Conceived and designed the experiments: HN MQD CDWP PM MB. Performed the experiments: HN RS HL HY MB. Analyzed the data: HN MB. Contributed reagents/materials/analysis tools: HN HL HY MQD CDWP PM MB. Wrote the paper: HN MQD CDWP PM MB.
###end p 1
###begin p 2
Current address: Institute for Molecular Cardiovascular Research (IMCAR), RWTH Aachen University, Aachen, Germany
###end p 2
###begin title 3
Background
###end title 3
###begin p 4
The translocation t(11;18)(q21;q21) is the most frequent chromosomal aberration associated with MALT lymphoma and results in constitutive NF-kappaB activity via the expression of an API2-MALT1 fusion protein. The properties of the reciprocal MALT1-API2 were never investigated as it was reported to be rarely transcribed.
###end p 4
###begin title 5
Principal Findings
###end title 5
###begin p 6
###xml 34 44 34 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1-API2</italic>
###xml 151 156 151 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1</italic>
###xml 161 165 161 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">API2</italic>
###xml 545 553 533 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 569 579 557 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1-API2</italic>
Our data indicate the presence of MALT1-API2 transcripts in the majority of t(11;18)(q21;q21)-positive MALT lymphomas. Based on the breakpoints in the MALT1 and API2 gene, the MALT1-API2 protein contains the death domain and one or both immunoglobulin-like domains of MALT1 (approximately90% of cases) - mediating the possible interaction with BCL10 - fused to the RING domain of API2. Here we show that this RING domain enables MALT1-API2 to function as an E3 ubiquitin ligase for BCL10, inducing its ubiquitination and proteasomal degradation in vitro. Expression of MALT1-API2 transcripts in t(11;18)(q21;q21)-positive MALT lymphomas was however not associated with a reduction of BCL10 protein levels.
###end p 6
###begin title 7
Conclusion
###end title 7
###begin p 8
As we observed MALT1-API2 to be an efficient target of its own E3 ubiquitin ligase activity, our data suggest that this inherent instability of MALT1-API2 prevents its accumulation and renders a potential effect on MALT lymphoma development via destabilization of BCL10 unlikely.
###end p 8
###begin title 9
Introduction
###end title 9
###begin p 10
###xml 290 295 290 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCL10</italic>
###xml 295 298 295 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Willis1">[1]</xref>
###xml 300 303 300 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Zhang1">[2]</xref>
###xml 312 317 312 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1</italic>
###xml 317 320 317 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Streubel1">[3]</xref>
###xml 322 325 322 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-SanchezIzquierdo1">[4]</xref>
###xml 370 373 370 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IgH</italic>
###xml 553 557 529 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">API2</italic>
###xml 566 571 542 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1</italic>
###xml 577 580 553 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Dierlamm1">[5]</xref>
###xml 582 585 558 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Remstein1">[6]</xref>
###xml 827 832 803 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1</italic>
###xml 1025 1031 977 983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004822-g001">Fig 1A</xref>
###xml 1033 1036 985 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Isaacson1">[7]</xref>
Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT), or MALT lymphoma, represents 7-8% of all B-cell lymphomas. Two translocations specifically associated with MALT lymphoma are t(1;14)(p22;q32) and t(14;18)(q32;q21), which upregulate the expression of the BCL10[1], [2] and the MALT1[3], [4] gene, respectively, via their fusion to the IgH enhancer. The most important translocation, present in approximately40% of pulmonary and approximately10-30% of gastric MALT lymphomas, is t(11;18)(q21;q21), which rearranges the API2 and the MALT1 gene [5], [6]. In approximately half of the cases, the resulting API2-MALT1 fusion protein contains the three N-terminal baculovirus IAP repeat (BIR) domains of API2 fused to the C-terminal caspase-like domain of MALT1. Depending on the breakpoint in the MALT1 gene however, the fusion protein can contain in addition one or two immunoglobulin (Ig)-like domains of MALT1, as observed in approximately40% and approximately10% of the cases, respectively (Fig 1A) [7].
###end p 10
###begin title 11
###xml 19 29 19 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1-API2</italic>
RT-PCR analysis of MALT1-API2 expression in t(11;18)(q21;q21)-positive MALT lymphoma.
###end title 11
###begin p 12
###xml 192 196 192 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">API2</italic>
###xml 207 212 207 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1</italic>
###xml 326 331 326 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1</italic>
###xml 363 367 363 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">API2</italic>
###xml 519 526 519 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004822-t001">Table 1</xref>
###xml 642 647 642 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1</italic>
###xml 652 657 652 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 754 764 754 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1-API2</italic>
###xml 766 776 766 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">API2-MALT1</italic>
###xml 781 786 781 786 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HPRT1</italic>
###xml 810 831 810 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 836 843 836 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004822-t002">Table 2</xref>
A, Features of MALT1, API2, and the fusion proteins API2-MALT1 and MALT1-API2. Indicated is the domain content (solid bars) of the API2-MALT1 fusion variants A7M3, A7M5, A7M8 and A7M9 (fusion API2 exon 7 to MALT1 exon 3/5/8/9, respectively) and their corresponding MALT1-API2 fusion variants M2A8, M4A8, M7A8 and M8A8 (fusion MALT1 exon 2/4/7/8, respectively, to API2 exon 8). B, Shown are the amplification products of nested PCR reactions on cDNA extracted from 14 t(11;18)(q21;q21)-positive MALT lymphoma cases (see Table 1). A PCR on pcD-F-M2A8, pcD-F-M4A8 and/or pcD-F-M8A8 was performed as positive control, as indicated. An RT-PCR for MALT1 and GAPDH was included for RNA quality control. C, Results of quantitative RT-PCR for cases 11 and 12 for MALT1-API2, API2-MALT1 and HPRT1. For primers used, see Materials and Methods and Table 2.
###end p 12
###begin p 13
###xml 224 227 224 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Eckelman1">[8]</xref>
###xml 347 350 347 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Huang1">[9]</xref>
###xml 434 438 434 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Hu1">[10]</xref>
API2 belongs to the inhibitor of apoptosis protein (IAP) family and has been implicated in anti-apoptotic processes, with an important role for its BIR domains as 'protein sink' for apoptosis mediators like caspase-3 and -7 [8]. In addition, a C-terminal really interesting new gene (RING) domain confers API2 with an E3 ubiquitin ligase activity [9], and ubiquitination-induced degradation of pro-apoptotic proteins like SMAC/DIABLO [10] might contribute significantly to its anti-apoptotic function.
###end p 13
###begin p 14
###xml 6 10 6 10 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Ruland1">[11]</xref>
###xml 12 16 12 16 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-RuefliBrasse1">[12]</xref>
###xml 27 31 27 31 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Ruland2">[13]</xref>
###xml 311 315 307 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Wang1">[14]</xref>
###xml 316 320 312 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Bidere1">[17]</xref>
###xml 459 463 455 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Oeckinghaus1">[18]</xref>
###xml 474 478 470 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Wu1">[19]</xref>
###xml 585 589 570 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Oeckinghaus1">[18]</xref>
###xml 591 595 576 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Wu1">[19]</xref>
###xml 732 736 706 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Zhou1">[20]</xref>
MALT1 [11], [12] and BCL10 [13] on the other hand are important players in the signalling cascade from the antigen receptors on B- and T-cells to the transcription factor NF-kappaB. Upon T-cell receptor (TCR) triggering, CARMA1 recruits the BCL10-MALT1-TRAF6 complex to the lipid rafts surrounding the receptor [14]-[17]. Raft-mediated oligomerization activates the E3 ubiquitin ligase activity of TRAF6, resulting in Lys63-linked polyubiquitination of MALT1 [18] and BCL10 [19]. This mediates the recruitment of the IKKalpha/IKKbeta/IKKgamma complex to the CARMA1-BCL10-MALT1 complex [18], [19] and induces full NF-kappaB activation via the phosphorylation of IKKbeta, together with the Lys63-linked polyubiquitination of IKKgamma [20]. The important function of MALT1 and BCL10 in antigen receptor signalling to NF-kappaB suggests a role for enhanced NF-kappaB activation in MALT lymphoma development.
###end p 14
###begin p 15
###xml 69 73 65 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Uren1">[21]</xref>
###xml 75 79 71 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Lucas1">[22]</xref>
###xml 115 119 107 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Zhou2">[23]</xref>
###xml 121 125 113 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Baens1">[24]</xref>
###xml 196 200 188 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Baens1">[24]</xref>
###xml 202 206 194 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Ho1">[25]</xref>
###xml 230 234 222 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Zhou2">[23]</xref>
###xml 452 456 440 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Noels1">[26]</xref>
###xml 543 547 527 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Ho1">[25]</xref>
###xml 549 553 533 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Stoffel1">[27]</xref>
###xml 636 640 620 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Hosokawa1">[28]</xref>
###xml 868 872 852 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Hu2">[29]</xref>
###xml 972 976 956 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Hu2">[29]</xref>
###xml 1060 1064 1044 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Liu1">[30]</xref>
###xml 1066 1070 1050 1054 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Maes1">[31]</xref>
Also API2-MALT1 has been linked to constitutive NF-kappaB activation [21], [22] via polyubiquitination of IKKgamma [23], [24]. The permanent association of the fusion protein with the lipid rafts [24], [25] or its oligomerization [23] via the first BIR domain bypasses the normal requirement of BCL10-mediated oligomerization of the MALT1-TRAF6 complex, resulting in TRAF6-mediated NF-kappaB activation without the need for antigen receptor triggering [26]. NF-kappaB activation by API2-MALT1 has been shown to upregulate anti-apoptotic genes [25], [27]. In addition, API2-MALT1 retains the ability of API2 to interact with SMAC/DIABLO [28], suggesting that API2-MALT1 also interferes indirectly with apoptotic signalling. In contrast to API2 however, API2-MALT1 has no E3 ubiquitin ligase activity and cannot ubiquitinate and target BCL10 for proteasomal degradation [29]. This could explain the increased BCL10 expression levels in MALT lymphomas with t(11;18)(q21;q21) [29], which, together with the unusual nuclear localization of BCL10 in these lymphomas [30], [31] have been suggested to contribute to the oncogenic character of this translocation. Altogether, these data point to divergent roles for API2-MALT1 in MALT lymphomagenesis.
###end p 15
###begin p 16
###xml 49 59 49 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1-API2</italic>
###xml 152 162 152 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1-API2</italic>
###xml 200 204 200 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Akagi1">[32]</xref>
###xml 205 209 205 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Motegi1">[34]</xref>
###xml 411 415 411 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Baens2">[35]</xref>
###xml 417 421 417 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Liu2">[36]</xref>
In contrast to API2-MALT1, the reciprocal fusion MALT1-API2 produced on the der(18) of the t(11;18)(q21;q21) escaped attention as initial reports found MALT1-API2 RNA not to be consistently expressed [32]-[34]. Analyses of the genomic breakpoints showed that although the translocation is accompanied by deletions, duplications and insertions, a MALT1-API2 fusion protein can be formed in the majority of cases [35], [36]. This raised the question whether the reciprocal fusion protein might hinder MALT lymphomagenesis and induce its own transcriptional silencing.
###end p 16
###begin p 17
###xml 148 153 148 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1</italic>
###xml 257 263 257 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004822-g001">Fig 1A</xref>
###xml 265 269 265 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Baens2">[35]</xref>
###xml 271 275 271 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Liu2">[36]</xref>
###xml 563 567 563 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Noels1">[26]</xref>
MALT1-API2 always contains the N-terminal death domain (DD) of MALT1 fused to the C-terminal RING domain of API2. Variability of the breakpoints in MALT1 generates MALT1-API2 fusion variants that can contain in addition one or two Ig-like domains of MALT1 (Fig 1A) [35], [36]. We recently showed that the DD and Ig-like domains of MALT1 cooperate for BCL10 binding, whereas two functional TRAF6 binding sites in MALT1, the first one directly 3' of the second Ig-like domain (T6-Ig) and the second in the MALT1 C-terminus (T6-C), are involved in TRAF6 recruitment [26]. The presence of these BCL10 and TRAF6 binding sites in some of the MALT1-API2 fusion variants in combination with the RING E3 ubiquitin ligase domain of API2 suggests that these MALT1-API2 proteins could bind BCL10 and/or TRAF6 and mark them for ubiquitination-induced degradation.
###end p 17
###begin p 18
###xml 39 49 39 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1-API2</italic>
###xml 494 502 494 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
In this study we provide evidence that MALT1-API2 expression is not generally silenced in t(11;18)(q21;q21)-positive MALT lymphomas. We furthermore show that the MALT1-API2 fusion variants with one or both Ig-like domains of MALT1 do bind BCL10 though fail to interact with TRAF6. The RING domain in addition provides MALT1-API2 with an E3 ubiquitin ligase activity, allowing the MALT1-API2 variant with one Ig-like domain to trigger ubiquitination and proteasome-mediated degradation of BCL10 in vitro. However, the RING domain also destabilizes MALT1-API2 itself via auto-ubiquitination-induced degradation. This inherent instability of MALT1-API2 most likely limits its protein level in t(11;18)(q21;q21)-positive MALT lymphomas and thus renders a possible effect on their development via destabilization of BCL10 unlikely.
###end p 18
###begin title 19
Results
###end title 19
###begin title 20
###xml 0 10 0 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1-API2</italic>
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT</italic>
MALT1-API2 expression in MALT lymphoma with t(11;18)(q21;q21)
###end title 20
###begin p 21
###xml 31 41 31 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1-API2</italic>
###xml 239 243 239 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Akagi1">[32]</xref>
###xml 244 248 244 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Motegi1">[34]</xref>
###xml 297 307 297 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1-API2</italic>
###xml 483 490 483 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004822-t001">Table 1</xref>
###xml 492 496 492 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Baens2">[35]</xref>
###xml 498 502 498 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Liu2">[36]</xref>
###xml 504 514 504 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1-API2</italic>
###xml 580 586 580 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004822-g001">Fig 1B</xref>
###xml 588 596 588 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004822.s001">Fig S1AB</xref>
###xml 598 605 598 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004822-t001">Table 1</xref>
###xml 669 679 669 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1-API2</italic>
###xml 786 796 786 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1-API2</italic>
###xml 869 879 869 879 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1-API2</italic>
###xml 915 919 915 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Liu2">[36]</xref>
###xml 984 994 984 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1-API2</italic>
###xml 1056 1061 1056 1061 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1</italic>
###xml 1093 1099 1093 1099 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004822-g001">Fig 1B</xref>
###xml 1156 1166 1156 1166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1-API2</italic>
###xml 1217 1227 1217 1227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1-API2</italic>
###xml 1280 1287 1280 1287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004822-t001">Table 1</xref>
Although initial reports found MALT1-API2 not to be expressed in the t(11;18)(q21;q21)-positive MALT lymphoma cases analyzed, no correlation was made with the genomic architecture at the breakpoint on the der(18) chromosome in these cases [32]-[34]. We therefore analyzed via RT-PCR expression of MALT1-API2 in 14 cases of t(11;18)(q21;q21)-positive MALT lymphoma, of which the fusion junctions on der(18) had previously been characterized at the genomic level in 10 of these cases (Table 1) [35], [36]. MALT1-API2 transcripts were identified in 8 out of the 14 cases (case 1-14, Fig 1B, Fig S1AB, Table 1). Sequencing of the PCR products was performed to identify the MALT1-API2 fusion variant and confirmed the generation of in-frame fusions in all cases. In the 6 cases for which no MALT1-API2 fusion could be detected via RT-PCR, one case (case 7) did not reveal a MALT1-API2 fusion at the genomic level either [36], while for 4 other cases (case 2, 3, 13 and 14), the absence of MALT1-API2 transcripts most likely reflects poor RNA quality as also no MALT1 transcript could be amplified (Fig 1B). In total, for 7 of the 9 cases for which previously a MALT1-API2 fusion was demonstrated at the genomic level, the MALT1-API2 variant could be confirmed at the transcript level (Table 1).
###end p 21
###begin title 22
Characteristics of the MALT lymphoma cases examined.
###end title 22
###begin p 23
###xml 15 19 15 19 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Liu2">[36]</xref>
###xml 19 45 19 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">data not shown for case 15</italic>
case number in [36]data not shown for case 15.
###end p 23
###begin p 24
###xml 15 19 15 19 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Baens2">[35]</xref>
case number in [35].
###end p 24
###begin p 25
###xml 18 22 18 22 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Baens2">[35]</xref>
###xml 24 28 24 28 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Liu2">[36]</xref>
data published in [35], [36].
###end p 25
###begin p 26
na = not analyzed.
###end p 26
###begin p 27
- = not found.
###end p 27
###begin p 28
###xml 53 63 53 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1-API2</italic>
###xml 93 103 93 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">API2-MALT1</italic>
###xml 154 159 154 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HPRT1</italic>
###xml 207 213 207 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004822-g001">Fig 1C</xref>
###xml 245 255 245 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">API2-MALT1</italic>
###xml 377 381 373 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">API2</italic>
###xml 391 395 387 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Hosokawa2">[37]</xref>
Quantitative RT-PCR furthermore showed that although MALT1-API2 is much lower expressed than API2-MALT1, its expression level is still about half that of HPRT1 and thus of potential biological significance (Fig 1C). The high expression level of API2-MALT1 reflects its potential to upregulate its own expression via activation of NF-kappaB, which drives transcription from the API2 promoter [37].
###end p 28
###begin p 29
###xml 53 63 53 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1-API2</italic>
In conclusion, these data argue against silencing of MALT1-API2 transcription in t(11;18)(q21;q21)-positive MALT lymphomas.
###end p 29
###begin title 30
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRAF6</italic>
###xml 61 71 61 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1-API2</italic>
BCL10 but not TRAF6 interacts with Ig-like domain-containing MALT1-API2 variants
###end title 30
###begin p 31
###xml 178 184 178 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004822-g001">Fig 1A</xref>
###xml 186 190 186 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Noels1">[26]</xref>
###xml 375 382 375 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 571 575 571 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-deBoer1">[38]</xref>
###xml 589 595 589 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004822-g001">Fig 1A</xref>
###xml 617 622 617 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1</italic>
###xml 636 640 636 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">API2</italic>
###xml 783 789 783 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004822-g001">Fig 1A</xref>
###xml 820 825 820 825 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1</italic>
###xml 854 858 854 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">API2</italic>
###xml 934 940 934 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004822-g002">Fig 2A</xref>
###xml 1130 1136 1130 1136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004822-g002">Fig 2A</xref>
###xml 1501 1507 1501 1507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004822-g002">Fig 2B</xref>
###xml 375 382 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
MALT1 requires its DD and Ig-like domains to bind BCL10, while TRAF6 is recruited to TRAF6 binding sites in the second Ig-like domain (T6-Ig) and the C-terminus (T6-C) of MALT1 (Fig 1A) [26]. To examine whether MALT1-API2 also recruits BCL10 and/or TRAF6, we transiently expressed the different MALT1-API2 fusion variants fused to a biotinylation (bio) tag together with the E. coli BirA biotin protein ligase in HEK-293T cells. Protein complexes of biotinylated MALT1-API2 were subsequently pulled-down with streptavidin-coated paramagnetic beads, as recently described [38]. While M2A8 (Fig 1A, fusion of exon 2 of MALT1 to exon 8 of API2) did not bind BCL10, the inclusion of one or two Ig-like domains of MALT1 in the MALT1-API2 fusion variants M4A8 and M7A8/M8A8, respectively (Fig 1A, fusion of exon 4, 7 and 8 of MALT1, respectively, to exon 8 of API2) resulted in co-precipitation of endogenous BCL10, similarly as for MALT1 (Fig 2A). In contrast, the presence of the TRAF6 binding site T6-Ig of MALT1 in M7A8 and M8A8 did not allow the recruitment of endogenous TRAF6, while TRAF6 efficiently co-precipitated with MALT1 (Fig 2A). To exclude cell-type specific interactions, we generated SSK41 Marginal Zone lymphoma B-cells stably expressing the BirA biotin ligase together with the bio-tagged M4A8 fusion variant. Streptavidin-mediated pull-down again showed an efficient co-purification of endogenous BCL10 with M4A8, despite its lower expression level in SSK41 compared to HEK-293T cells (Fig 2B).
###end p 31
###begin title 32
MALT1-API2 interacts with BCL10 via the MALT1 Ig-like domains.
###end title 32
###begin p 33
A, Inclusion of one or two Ig-like domains of MALT1 in MALT1-API2 allows the binding of endogenous BCL10 in HEK-293T. Immunoblot with alpha-TRAF6, alpha-BCL10 and alpha-Flag on protein complexes co-precipitated with Flag-bio-tagged M2A8, M4A8, M7A8, M8A8 and MALT1, transiently expressed in HEK-293T cells. B, M4A8 binds endogenous BCL10 in SSK41 B-cells. Immunoblot with alpha-BCL10 and alpha-Flag on protein complexes pulled down with Flag-bio-tagged M4A8 stably expressed in SSK41-BirA B-cells. Precipitated protein complexes from two different SSK41-BirA-M4A8 clones (69 and 93) were compared to the protein complex from HEK-293T cells with transient overexpression of M4A8. Molecular weight standards are in kDa.
###end p 33
###begin p 34
In conclusion, our data show that the combination of the DD with one or two Ig-like domains of MALT1 in MALT1-API2 facilitates the interaction with BCL10, but not with TRAF6.
###end p 34
###begin title 35
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M4A8</italic>
M4A8 ubiquitinates BCL10 via its RING domain
###end title 35
###begin p 36
###xml 105 108 105 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Huang1">[9]</xref>
###xml 110 114 110 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Yang1">[39]</xref>
###xml 158 162 158 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Hu1">[10]</xref>
###xml 164 168 164 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Park1">[40]</xref>
###xml 169 173 169 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Varfolomeev1">[42]</xref>
###xml 240 244 240 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Hu2">[29]</xref>
###xml 714 720 706 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004822-g003">Fig 3A</xref>
###xml 867 873 859 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004822-g003">Fig 3A</xref>
###xml 1149 1155 1141 1147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004822-g003">Fig 3A</xref>
###xml 1254 1260 1246 1252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004822-g003">Fig 3A</xref>
###xml 1345 1349 1337 1341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Hu2">[29]</xref>
###xml 1412 1418 1404 1410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004822-g003">Fig 3A</xref>
###xml 1610 1616 1597 1603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004822-g003">Fig 3B</xref>
The RING domain of API2 enables it to function as an E3 ubiquitin ligase, capable of auto-ubiquitination [9], [39] and ubiquitination of interacting proteins [10], [40]-[42], like BCL10 via its interaction with the first BIR domain of API2 [29]. We thus wondered whether also MALT1-API2 possessed E3 ubiquitin ligase activity. The different bio-tagged MALT1-API2 fusion variants were therefore transiently expressed in HEK-293T cells together with HA-tagged ubiquitin (Ub) and subsequently purified via streptavidin-mediated pull-down. Western blot analysis with alpha-Flag (for API2 and MALT-API2) and alpha-HA (for HA-Ub) clearly showed that all MALT1-API2 fusion variants were ubiquitinated, similarly as API2 (Fig 3A). Furthermore, mutation of the critical His and the two flanking Cys residues of the RING domain (RING mutant; RM) abolished most ubiquitination (Fig 3A), indicating auto-ubiquitination of MALT1-API2. Interestingly, cellular BCL10 co-purified with bio-tagged M4A8, and to a much lesser extent with M7A8, showed a similar pattern of ubiquitination, which again was completely dependent on a functional RING domain in MALT1-API2 (Fig 3A). Remarkably, we were not able to co-precipitate BCL10 together with bio-tagged full-length API2 (Fig 3A), in contrast to a recent report on the BIR-mediated interaction of BCL10 with API2 [29]. To exclude that the slower migrating BCL10 bands observed in Fig 3A resulted from BCL10 phosphorylation, protein complexes co-purified with bio-tagged wild-type (WT) M4A8 were treated with lambda-PPase, but this did not affect the migration pattern of BCL10 (Fig 3B).
###end p 36
###begin title 37
BCL10 is a target of the RING E3 ubiquitin ligase activity of MALT1-API2 variants with MALT1 Ig-like domains.
###end title 37
###begin p 38
A-B, Flag-bio-tagged M2A8, M4A8 and M7A8 (wild-type (WT) or RING mutant (RM)), API2 and empty vector were transiently expressed together with HA-Ub in HEK-293T. Protein complexes were precipitated with streptavidin-coated paramagnetic beads and analyzed with alpha-Flag, alpha-HA (after stripping of alpha-Flag) and alpha-BCL10. A, Mono- and di-ubiquitinated bands of WT MALT1-API2 and API2 are indicated with asterisks in the alpha-Flag and alpha-HA panel. B, Where indicated, the precipitated protein complex was treated with lambda-PPase to remove phosphorylation. C-D, BCL10 ubiquitination by M4A8 becomes more pronounced after inhibition of the proteasome. HA-bio-tagged BCL10 was transiently overexpressed in HEK-293T together with Flag-tagged M4A8 (WT or RM) or empty vector. Where indicated, cells were pretreated with MG132 to inhibit to proteasome. C, Cell lysates were immunodetected with alpha-BCL10 and alpha-HA (both for HA-BCL10), alpha-Flag and alpha-beta-actin. BCL10 ubiquitination is indicated with asterisks. D, Following denaturation of the cell lysates, HA-bio-tagged BCL10 was precipitated via streptavidin pull-down and where indicated, treated with lambda-PPase to remove phosphorylation. The bio-IPs were then immunodetected with alpha-BCL10, alpha-Flag (to check if the denaturation was complete) and alpha-Ub. BCL10 ubiquitination is indicated with asterisks. Molecular weight standards are in kDa.
###end p 38
###begin p 39
###xml 392 398 384 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004822-g003">Fig 3C</xref>
###xml 594 600 586 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004822-g003">Fig 3C</xref>
###xml 766 772 754 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004822-g003">Fig 3D</xref>
###xml 942 948 925 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004822-g003">Fig 3D</xref>
###xml 1033 1039 1012 1018 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004822-g003">Fig 3D</xref>
To further investigate these BCL10 modifications by M4A8, we transiently expressed HA-bio-tagged BCL10 in HEK-293T cells, alone or in combination with Flag-tagged WT- or RM-M4A8. While no effect of the RING mutant M4A8 on BCL10 was seen in the cell lysate, co-expression of BCL10 with wild-type M4A8 again induced BCL10 modifications (indicated with asterisks, alpha-BCL10 and alpha-HA panel Fig 3C). When the cells were treated with the proteasomal inhibitor MG132 prior to harvesting, the BCL10 modifications became more pronounced, further suggesting that M4A8 induces BCL10 ubiquitination (Fig 3C). This was even more obvious when BCL10 was purified via streptavidin pull-down in denaturing conditions to destroy existing protein interactions (alpha-BCL10 panel Fig 3D, left part). Again, phosphorylation could be excluded, since treatment of the purified BCL10 proteins with lambda-PPase did not affect the slower migrating BCL10 bands (Fig 3D, right part). In contrast, these bands could be revealed with an alpha-Ub antibody (Fig 3D).
###end p 39
###begin p 40
Altogether, these data indicate that MALT1-API2 can function as an E3 ubiquitin ligase via the RING domain of API2. While all fusion variants auto-ubiquitinate, only M4A8 is able to induce significant BCL10 ubiquitination in overexpression experiments.
###end p 40
###begin title 41
###xml 27 31 27 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M4A8</italic>
Ubiquitination of BCL10 by M4A8 induces its degradation by the proteasome
###end title 41
###begin p 42
###xml 85 89 85 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Hu1">[10]</xref>
###xml 91 95 91 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Hu2">[29]</xref>
###xml 97 101 97 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Yang1">[39]</xref>
###xml 102 106 102 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Varfolomeev1">[42]</xref>
###xml 231 237 231 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004822-g004">Fig 4B</xref>
###xml 291 312 291 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 394 400 394 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004822-g004">Fig 4A</xref>
###xml 715 722 715 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004822-g004">Fig 4BC</xref>
###xml 843 849 843 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004822-g004">Fig 4B</xref>
###xml 947 953 947 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004822-g003">Fig 3A</xref>
###xml 1048 1054 1048 1054 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004822-g004">Fig 4A</xref>
###xml 1119 1125 1119 1125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004822-g002">Fig 2A</xref>
The RING domains of IAPs are involved in ubiquitination-mediated protein degradation [10], [29], [39]-[42]. As we consistently observed a lower expression level for the wild-type MALT1-API2 proteins compared to their RING mutants (Fig 4B) even though more DNA was used for transfection (see Materials and Methods), we expected that also MALT1-API2 targets proteins for degradation. As shown in Fig 4A, expression of M4A8 in HEK-293T indeed reduced the BCL10 protein level. A smaller effect was seen for M7A8, while M2A8 did not affect the BCL10 level. Like its polyubiquitination, also the reduction of BCL10 levels by M4A8 and M7A8 was dependent on a functional RING domain, as the RING mutant (RM) had no effect (Fig 4BC). In contrast to M4A8 and M7A8, expression of wild-type API2 did not affect BCL10 protein levels, like its RING mutant (Fig 4B), which is in agreement with our observation that BCL10 does not interact with API2 in HEK-293T (Fig 3A). Similarly, none of the MALT1-API2 fusion variants had an effect on the TRAF6 protein level (Fig 4A), conform the absence of TRAF6 in MALT1-API2 protein complexes (Fig 2A).
###end p 42
###begin title 43
M4A8 induces BCL10 degradation by the proteasome.
###end title 43
###begin p 44
###xml 1729 1730 1656 1657 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
A, M4A8, and to a lesser extent M7A8, induces BCL10 degradation. Cell lysates of HEK-293T cells, transiently transfected with empty vector or increasing concentrations of Flag-tagged M2A8, M4A8 and M7A8 were immunodetected with alpha-Flag, alpha-BCL10, alpha-TRAF6 and alpha-beta-actin. The BCL10 protein level (%) is compared to empty vector-transfected cells after normalization to beta-actin. B, M4A8 requires a functional RING domain to induce BCL10 degradation. HEK-293T cells, transiently transfected with empty vector or Flag-tagged M2A8, M4A8, M7A8 and API2 (WT or RM) were lysed and immunodetected with alpha-Flag, alpha-BCL10 and alpha-beta-actin. The BCL10 protein level (%) is compared to empty vector-transfected cells after normalization to beta-actin and represents the mean of three independent experiments, with indicated standard deviation. C, HEK-293T cells were transiently transfected with empty vector or increasing concentrations of Flag-tagged WT or RM M4A8. Cell lysates were analyzed with alpha-Flag, alpha-BCL10 and alpha-beta-actin. The BCL10 protein level (%) is compared to empty vector-transfected cells after normalization to beta-actin. D-E, Proteasome inhibition reduces the degradation of BCL10 and of M4A8 itself. HEK-293T cells, transiently transfected with empty vector or increasing concentrations of Flag-tagged M4A8 were pretreated with DMSO, MG132 (D) or lactacystin (E) prior to harvesting. Cell lysates were analyzed with alpha-Flag, alpha-BCL10 and alpha-beta-actin. F, Degradation of BCL10 or MALT1-API2 does not require the lysosome. HEK-293T cells, transiently transfected with empty vector or increasing concentrations of Flag-tagged M4A8 were left untreated or pretreated with NH4Cl prior to harvesting. Cell lysates were analyzed with alpha-Flag, alpha-BCL10, alpha-TRAF6 and alpha-beta-actin.
###end p 44
###begin p 45
###xml 298 304 298 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004822-g004">Fig 4D</xref>
###xml 421 427 421 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004822-g004">Fig 4E</xref>
###xml 503 504 503 504 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 538 544 538 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004822-g004">Fig 4F</xref>
To determine whether BCL10 degradation occurred via the proteasome or the lysosome, we tested the effect of inhibitors on BCL10 protein levels in HEK-293T cells expressing M4A8. Pretreatment of HEK-293T with MG132 prevented BCL10 degradation, even though the M4A8 level increased at the same time (Fig 4D). The same result was obtained when cells were pretreated with the more specific proteasomal inhibitor lactacystin (Fig 4E), while BCL10 degradation upon M4A8 expression could not be blocked with NH4Cl, an inhibitor of the lysosome (Fig 4F).
###end p 45
###begin p 46
Altogether, these data indicate that the RING domain of M4A8 induces proteasome-mediated degradation of BCL10.
###end p 46
###begin title 47
###xml 14 24 14 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1-API2</italic>
###xml 120 124 120 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT</italic>
Expression of MALT1-API2 does not affect the BCL10 protein level and nuclear localization in t(11;18)(q21;q21)-positive MALT lymphoma
###end title 47
###begin p 48
###xml 32 42 32 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1-API2</italic>
###xml 77 84 77 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 222 232 222 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1-API2</italic>
###xml 259 263 259 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M8A8</italic>
###xml 370 380 370 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1-API2</italic>
###xml 396 402 396 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004822-g005">Fig 5A</xref>
###xml 464 468 464 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M8A8</italic>
###xml 632 638 632 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004822-g005">Fig 5B</xref>
###xml 688 694 688 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M4A8/9</italic>
###xml 929 935 929 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004822-g005">Fig 5A</xref>
###xml 1117 1123 1117 1123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M4A8/9</italic>
###xml 1148 1152 1148 1152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M8A8</italic>
###xml 1169 1176 1169 1176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004822-t001">Table 1</xref>
To assess whether expression of MALT1-API2 also affects BCL10 protein levels in vivo, we performed western blot analysis to evaluate BCL10 protein levels in t(11;18)(q21;q21)-positive MALT lymphoma samples with or without MALT1-API2 expression. Expression of M8A8 (case 4 and 5) was associated with reduced BCL10 levels when compared to two cases without the reciprocal MALT1-API2 (case 7 and 8, Fig 5A). Analysis of an additional case however showed no effect of M8A8 expression (case 11), although BCL10 expression was strongly upregulated compared to t(11;18)(q21;q21)-negative MALT lymphoma cases, control spleen or lymph node (Fig 5B). In contrast, two of the three samples with the M4A8/9 variant, which induced the highest levels of BCL10 ubiquitination and degradation in HEK-293T cells, showed an increase in BCL10 expression levels (case 9 and 10), whereas a small reduction was observed in the remaining case (case 1, Fig 5A). Furthermore, immunohistochemistry showed a nuclear localization of BCL10 for all cases examined, with no differences between cases without (case 2, 7 and 8) or with expression of M4A8/9 (case 1,6, 9 and 10) or M8A8 (case 4 and 5) (Table 1; data not shown).
###end p 48
###begin title 49
###xml 14 24 14 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1-API2</italic>
Expression of MALT1-API2 does not affect the BCL10 protein level in t(11;18)(q21;q21)-positive MALT lymphoma.
###end title 49
###begin p 50
###xml 169 179 154 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">API2-MALT1</italic>
###xml 184 194 169 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1-API2</italic>
###xml 221 228 206 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004822-t001">Table 1</xref>
A, Lysates of 7 MALT lymphoma samples were immunodetected with alpha-MALT1-C, alpha-BCL10 and alpha-beta-actin to evaluate the BCL10 protein level. Specifications about API2-MALT1 and MALT1-API2 transcript variants (from Table 1) are indicated. The BCL10 and MALT1 protein level (%) is compared to case 7 after normalization to beta-actin. Different parts of the same blot were combined as indicated via the dotted lines. B, Immunoblot with alpha-BCL10 and alpha-beta-actin on lysates from 4 MALT lymphoma cases (with specifications as indicated) and control spleen and lymph node samples. Different parts of the same blot were combined as indicated via the dotted lines.
###end p 50
###begin p 51
###xml 54 64 54 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1-API2</italic>
In conclusion, these data do not suggest an effect of MALT1-API2 expression on BCL10 protein levels and nuclear staining in these MALT lymphomas.
###end p 51
###begin title 52
###xml 0 10 0 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1-API2</italic>
###xml 43 53 39 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">API2-MALT1</italic>
MALT1-API2 reduces NF-kappaB activation by API2-MALT1
###end title 52
###begin p 53
###xml 286 291 282 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004822-g006">Fig 6</xref>
Finally, the effect of MALT1-API2 expression on API2-MALT1-mediated NF-kappaB activation was examined by co-expression of the different API2-MALT1 fusion variants A7M3/A7M5/A7M8 in combination with their corresponding WT or RM MALT1-API2 variant M2A8/M4A8/M7A8 in HEK-293T. As shown in Fig 6, all MALT1-API2 fusion variants reduced NF-kappaB activation by API2-MALT1 to a similar extent. Although this was partly associated with an intact RING domain in MALT1-API2, MALT1-API2 also significantly affected NF-kappaB signalling independently of its E3 ubiquitin ligase activity.
###end p 53
###begin title 54
MALT1-API2 reduces NF-kappaB activation by API2-MALT1.
###end title 54
###begin p 55
NF-kappaB-dependent luciferase assay after co-expression of API2-MALT1 (A7M3/A7M5/A7M8) with its corresponding MALT1-API2 fusion variant (M2A8/M4A8/M7A8) in HEK-293T. NF-kappaB-dependent luciferase activity is represented as fold induction of vector-transfected cells. Shown is one representative experiment of 2, performed in triplicate, with mean and standard deviation. Lysates were immunodetected with alpha-Flag to confirm comparable API2-MALT1 expression in all cases.
###end p 55
###begin title 56
Discussion
###end title 56
###begin p 57
###xml 366 376 362 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1-API2</italic>
###xml 461 471 457 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1-API2</italic>
###xml 597 607 593 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1-API2</italic>
###xml 916 924 912 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 986 996 982 992 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1-API2</italic>
The translocation t(11;18)(q21;q21) is a frequent genomic aberration associated with B-cell MALT lymphoma. Nowadays, it is generally accepted that the API2-MALT1 fusion protein expressed from the der(11) contributes to B-cell transformation and progression of MALT lymphomas via constitutive NF-kappaB activation. In contrast, not much is known about the reciprocal MALT1-API2 fusion generated on the der(18) chromosome. Although it was initially reported that MALT1-API2 is not consistently transcribed, we show here that the majority of MALT lymphomas with t(11;18)(q21;q21) do express in-frame MALT1-API2 transcripts. Our data furthermore show that the RING domain of API2 provides MALT1-API2 with an E3 ubiquitin ligase activity. In addition, the inclusion of at least one Ig-like domain of MALT1 in MALT1-API2 results in the binding and ubiquitination of BCL10, which triggers its degradation by the proteasome in vitro. However, no correlation was found between the presence of a MALT1-API2 transcript and the BCL10 expression level and nuclear staining in MALT lymphoma samples, most likely due to the efficient downregulation of MALT1-API2 protein levels via auto-ubiquitination.
###end p 57
###begin p 58
###xml 47 57 47 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1-API2</italic>
###xml 121 125 121 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Akagi1">[32]</xref>
###xml 126 130 126 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Motegi1">[34]</xref>
###xml 265 275 265 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1-API2</italic>
###xml 405 409 405 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Akagi1">[32]</xref>
###xml 479 483 479 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">API2</italic>
###xml 495 500 495 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1</italic>
###xml 581 591 581 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1-API2</italic>
###xml 618 628 618 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1-API2</italic>
###xml 714 718 714 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">API2</italic>
###xml 731 735 731 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Baens2">[35]</xref>
###xml 820 825 820 825 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1</italic>
###xml 861 865 861 865 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">API2</italic>
###xml 1093 1103 1093 1103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1-API2</italic>
###xml 1289 1293 1289 1293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">API2</italic>
###xml 1323 1328 1323 1328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1</italic>
###xml 1348 1352 1348 1352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Liu2">[36]</xref>
###xml 1415 1425 1415 1425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1-API2</italic>
###xml 1474 1484 1474 1484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1-API2</italic>
###xml 1524 1534 1524 1534 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1-API2</italic>
###xml 1655 1665 1655 1665 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1-API2</italic>
###xml 1759 1769 1759 1769 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1-API2</italic>
###xml 1797 1804 1797 1804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004822-t001">Table 1</xref>
###xml 1861 1871 1861 1871 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1-API2</italic>
Initial reports could not detect expression of MALT1-API2 in the t(11;18)(q21;q21)-positive MALT lymphoma cases examined [32]-[34]. It is possible that the t(11;18)(q21;q21) is accompanied by deletions or other genomic aberrations that obstruct the generation of a MALT1-API2 fusion on der(18). One group indeed reported deletions 5' of the breakpoint on der(18) in all three MALT lymphoma cases examined [32]. Similarly, while only small intronic deletions were detected in the API2 and/or the MALT1 gene in three t(11;18)(q21;q21)-positive MALT lymphoma cases with expression of MALT1-API2, the failure to amplify a MALT1-API2 transcript in two other cases correlated with a deletion of a substantial part of 3'-API2 on der(18) ([35] and Baens, unpublished results). Such deletion involving the N-terminal part of the MALT1 gene or the C-terminal part of the API2 gene is however not a general observation in MALT lymphomas with t(11;18)(q21;q21), as a more recent genomic characterization of 19 t(11;18)(q21;q21)-positive MALT lymphomas demonstrated in 13 cases the generation of a genomic MALT1-API2 fusion, with only small and mostly intronic deletions, duplications and/or insertions. Only in the 6 cases for which the amplification failed, deletions involving the entire C-terminal API2 and/or the entire N-terminal MALT1 gene were expected [36]. To address this apparent discrepancy between the presence of MALT1-API2 fusions at the genomic level and the absence of MALT1-API2 transcripts, we analyzed in this study MALT1-API2 expression in 14 t(11;18)(q21;q21)-positive MALT lymphoma cases, of which 9 cases were previously reported to contain a MALT1-API2 fusion at the genomic level. Surprisingly, RT-PCR and sequencing confirmed the expression of MALT1-API2 in 7 out of these 9 cases (Table 1), which clearly shows that transcriptional silencing of MALT1-API2 is not a general phenomenon in t(11;18)(q21;q21)-positive MALT lymphomas.
###end p 58
###begin p 59
###xml 32 36 32 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">API2</italic>
###xml 41 46 41 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1</italic>
###xml 112 115 112 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Isaacson1">[7]</xref>
###xml 370 376 370 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004822-g001">Fig 1A</xref>
###xml 495 499 495 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Baens2">[35]</xref>
###xml 501 505 501 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Liu2">[36]</xref>
###xml 721 725 721 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Noels1">[26]</xref>
###xml 1079 1083 1079 1083 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Noels1">[26]</xref>
###xml 1359 1363 1359 1363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Noels1">[26]</xref>
Based on the breakpoints in the API2 and MALT1 gene, a number of API2-MALT1 fusion variants have been described [7]. For all these variants, the anticipated reciprocal MALT1-API2 fusion protein always contains the N-terminal DD of MALT1 and the C-terminal RING domain of API2. The majority of cases however could contain in addition one or two Ig-like domains of MALT1 (Fig 1A, the M4A8 and M7A8/M8A8 fusion variants), as also demonstrated via genomic characterization of the der(18) chromosome [35], [36]. Here we show that the inclusion of at least one Ig-like domain mediates the binding of MALT1-API2 to BCL10, conform our previous observation that the DD and the Ig-like domains of MALT1 cooperate for BCL10 binding [26]. In contrast, TRAF6 did not interact with any of the fusion variants, despite the presence of the TRAF6 binding site associated with the second Ig-like domain (T6-Ig) of MALT1 in M7A8 and M8A8. This probably reflects conformational constraints imposed by the C-terminal domains of API2, as full-length MALT1 efficiently interacted with endogenous TRAF6 [26], or indicates the necessity of C-terminal sequences of MALT1 for efficient binding of TRAF6 to this site. In favour of the latter is our observation that deletion of the C-terminus of MALT1 in the API2-MALT1 fusion variant A7M3 also abolished TRAF6 binding to the T6-Ig site [26].
###end p 59
###begin p 60
###xml 328 331 328 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Huang1">[9]</xref>
###xml 333 337 333 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Yang1">[39]</xref>
###xml 376 380 376 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Park1">[40]</xref>
###xml 388 392 388 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Lee1">[41]</xref>
###xml 402 406 402 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Hu1">[10]</xref>
###xml 547 551 547 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Hu2">[29]</xref>
###xml 868 872 868 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Noels1">[26]</xref>
###xml 1035 1039 1035 1039 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Hu2">[29]</xref>
###xml 1041 1045 1041 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Yui1">[43]</xref>
RING domains are able to catalyze the transfer of ubiquitin to a substrate. Our data show that the RING domain of API2 also enables MALT1-API2 to function as an E3 ubiquitin ligase capable of auto-ubiquitination, similarly as API2. Indeed, API2 is a known E3 protein involved in the ubiquitination-induced degradation of itself [9], [39] and of interacting proteins like RIP1 [40], TRAF1 [41] and SMAC [10]. Also BCL10 has recently been reported to be a target of API2-induced ubiquitination and degradation via binding to the BIR1 domain of API2 [29]. In this study, we were however unable to detect an interaction between API2 and endogenous BCL10, nor did we observe a RING-dependent effect of API2 overexpression on BCL10 stability. Although this confirms our previous observation that endogenous BCL10 does not interact with the BIR domains of API2 in API2-MALT1 [26], it needs to be determined whether the use of different cell types underlies this discrepancy or whether the interaction of BCL10 with API2 is stimulus-dependent [29], [43]. Nevertheless, we did detect a RING domain-dependent ubiquitination of BCL10 by M4A8, resulting in the degradation of BCL10 by the proteasome. Furthermore, while the inclusion of the second Ig-like domain of MALT1 in M7A8 somewhat increased its capacity to bind BCL10, this fusion variant could only modestly induce BCL10 ubiquitination and degradation, again suggesting conformational constraints.
###end p 60
###begin p 61
###xml 86 90 82 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Stoffel1">[27]</xref>
###xml 185 193 177 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 517 521 501 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Noels1">[26]</xref>
###xml 1350 1354 1318 1322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Zhou2">[23]</xref>
Given the importance of NF-kappaB activation to the oncogenic behaviour of API2-MALT1 [27], the effect of MALT1-API2 expression on API2-MALT1-mediated NF-kappaB activation was examined in vitro. Interestingly, all MALT1-API2 fusion variants were found to severely reduce NF-kappaB activation by API2-MALT1, partly via the presence of an intact RING domain. This can however not be explained by the RING-mediated ubiquitination and degradation of BCL10, as BCL10 is not required for NF-kappaB activation by API2-MALT1 [26]. Further studies are thus needed to investigate whether the RING E3 ubiquitin ligase activity of MALT1-API2 affects specific proteins involved in API2-MALT1-mediated signalling to NF-kappaB. Furthermore, these studies could provide insight into the E3 ubiquitin ligase-independent mechanism of MALT1-API2 to reduce NF-kappaB activation by API2-MALT1. As this could possibly involve the DD of MALT1 and/or the CARD (caspase recruitment domain) of API2, the identification of interaction partners for these domains would form the subject of interesting future research. Moreover, it remains to be investigated whether expression of MALT1-API2 also reduces API2-MALT1-mediated NF-kappaB activation in t(11;18)(q21;q21)-positive MALT lymphomas, for example by analyzing its effect on the Lys63-linked polyubiquitination of IKKgamma [23]. Unfortunately we were unable to do so in this study due to insufficient MALT lymphoma material available.
###end p 61
###begin p 62
###xml 90 94 86 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Hu2">[29]</xref>
###xml 141 145 137 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Liu1">[30]</xref>
###xml 147 151 143 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Maes1">[31]</xref>
###xml 305 313 301 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 471 481 467 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1-API2</italic>
###xml 660 664 656 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M4A8</italic>
###xml 696 704 692 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
In addition to NF-kappaB activation by API2-MALT1, also the increased BCL10 protein level [29] and the unusual nuclear localization of BCL10 [30], [31] have been suggested to contribute to the oncogenic character of the t(11;18)(q21;q21) in MALT lymphomas. The destabilizing effect of MALT1-API2 on BCL10 in vitro thus suggests that MALT1-API2 could also interfere in this way with the development of t(11;18)(q21;q21)-positive MALT lymphomas. However, the expression of MALT1-API2 did not affect the nuclear staining of BCL10 in our MALT lymphoma cases analyzed. In addition, we could not confirm decreased levels of BCL10 in MALT lymphoma B-cells expressing M4A8, this in sharp contrast to our in vitro observations. As MALT1-API2 is very unstable being an efficient target of its own E3 ubiquitin ligase activity, this suggests that its protein level in MALT lymphoma might be too low to affect BCL10 stability and localization. Unfortunately, we were not able to validate this further due to the lack of good quality antibodies able to detect the MALT1-API2 protein.
###end p 62
###begin p 63
In conclusion, our data show that the MALT1-API2 fusions with one or both Ig-like domains of MALT1 can bind BCL10 and induce its ubiquitination and proteasome-mediated degradation via the RING domain of API2. However, MALT1-API2 is also an efficient target of its own E3 ubiquitin ligase activity. This property of MALT1-API2 most likely limits its protein level in t(11;18)(q21;q21)-positive B-cells and makes a possible effect on MALT lymphoma development via destabilization of BCL10 unlikely.
###end p 63
###begin title 64
Materials and Methods
###end title 64
###begin title 65
Constructs
###end title 65
###begin p 66
###xml 107 111 107 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Noels1">[26]</xref>
###xml 287 292 287 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1</italic>
###xml 308 312 308 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">API2</italic>
###xml 314 320 314 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004822-g001">Fig 1A</xref>
Vectors enabling expression of biotinylated proteins (pcD-F-bio; pcD-HA-bio) were constructed as described [26] and used to generate constructs for MALT1, BCL10, API2, ubiquitin (Ub), the MALT1-API2 fusion variants M2A8, M4A8, M7A8 and M8A8 (fusion of respectively exon 2, 4, 7 and 8 of MALT1 with exon 8 of API2, Fig 1A) and their RING mutants (RM). PCR-based mutagenesis was used to introduce the triple mutation of the Zinc coordinating Histidine and the flanking Cysteines (C572S/H574A/C578S) in the RING domain of API2, which was subcloned in API2 and the MALT1-API2 constructs to create the corresponding RM.
###end p 66
###begin title 67
Cell culture, transfection and NF-kappaB reporter assays
###end title 67
###begin p 68
###xml 160 164 160 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Noels1">[26]</xref>
###xml 224 228 224 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Noels1">[26]</xref>
###xml 518 522 518 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Noels1">[26]</xref>
###xml 578 582 574 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Noels1">[26]</xref>
Monoclonal SSK41 B-cell lines stably expressing Flag-tagged BirA, alone or in combination with a Flag-bio-tagged M4A8, were generated and cultured as described [26]. HEK-293T cells were cultured and transfected as described [26]. For transfections involving MALT1-API2, a double amount of DNA of the wild-type MALT1-API2 variants compared to their RING mutants was used to obtain more equal expression levels. After 24 hours, cells were harvested in 1xPBS and lysed in a non-denaturing NDLB lysis buffer, as described [26]. NF-kappaB reporter assays were performed as described [26].
###end p 68
###begin title 69
Inhibition of the lysosome and the proteasome
###end title 69
###begin p 70
###xml 684 685 662 663 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
To inhibit the proteasome, cells were treated for 4 to 7 hours with 50 microM MG132 (VWR International) or with 25 microM lactacystin (Cayman, Bio-Connect, Huissen, The Netherlands) prior to harvesting. DMSO treatment was included as a control. To measure proteasome activity, 100 microg of cell lysate (20 mM Tris-Cl pH 8.0, 0.5 mM EDTA, 0.035% SDS) was incubated with 200 microM Suc-LLVY-AFC (Sigma-Aldrich, Bornem, Belgium) for 30 min on 37degreesC, after which released AFC was quantified (excitation 390 nm, emission 460 nm) using a FLUOstar Galaxy Plate Reader (BMG Labtechnologies GmbH, Offenburg, Germany). To inhibit the lysosome, cells were treated for 4 hours with 50 mM NH4Cl prior to harvesting.
###end p 70
###begin title 71
Bio-IP and phosphatase treatment
###end title 71
###begin p 72
###xml 47 51 47 51 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-deBoer1">[38]</xref>
###xml 79 83 79 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Noels1">[26]</xref>
The biotin-immunoprecipitation (bio-IP) method [38] was performed as described [26]. Where indicated, cell lysates were denatured in the presence of 1% SDS prior to bio-IP. To remove phosphorylations following bio-IP, where indicated, beads were resuspended in 1x lambda protein phosphatase (lambda-PPase) reaction buffer and treated with lambda-PPase (New England Biolabs, Westburg BV, Leusden, The Netherlands).
###end p 72
###begin title 73
SDS-PAGE and western blot analysis
###end title 73
###begin p 74
###xml 63 67 63 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Noels1">[26]</xref>
###xml 473 477 470 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Baens1">[24]</xref>
###xml 401 407 <span type="species:ncbi:9986">rabbit</span>
SDS-PAGE and western blot analysis were performed as described [26]. Antibodies used for immunodetection of the Flag epitope (M2) and of beta-actin (clone AC-15) were from Sigma-Aldrich, of the HA epitope (12CA5) from Roche Diagnostics Belgium (Vilvoorde, Belgium) and of BCL10 (sc-5273), TRAF6 (sc-7221) and Ub (sc-8017) from Santa Cruz Biotechnology (Tebu-bio, Boechout, Belgium). Anti-MALT1-C is a rabbit polyclonal antiserum raised against amino acids 731-824 of MALT1 [24]. The signal was visualized with the enhanced chemoluminescence (ECL) system (Perkin Elmer, Zaventem, Belgium) and, where indicated, quantified using the Advanced Image Data Analyzer (AIDA) Software (Raytest BeNeLux B.V., Tilburg, The Netherlands). Where indicated, membranes were stripped (62.5 mM Tris-Cl pH 6.7, 2% SDS and 100 mM beta-mercaptoethanol) for 30 min at 60degreesC and, prior to reprobing, analyzed via western blot detection with the appropriate secondary antibody to verify complete stripping.
###end p 74
###begin title 75
MALT lymphoma samples
###end title 75
###begin p 76
###xml 309 316 309 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004822-t001">Table 1</xref>
###xml 345 355 345 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">API2-MALT1</italic>
###xml 424 431 424 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004822-t001">Table 1</xref>
###xml 433 437 433 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Baens2">[35]</xref>
###xml 439 443 439 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Liu2">[36]</xref>
###xml 550 557 550 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004822-t001">Table 1</xref>
###xml 559 563 559 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Baens2">[35]</xref>
###xml 565 569 565 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Liu2">[36]</xref>
###xml 871 872 871 872 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1025 1029 1025 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Liu1">[30]</xref>
###xml 1049 1053 1049 1053 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Baens2">[35]</xref>
###xml 1126 1130 1126 1130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004822-Liu1">[30]</xref>
Fifteen cases of t(11;18)(q21;q21)-positive MALT lymphoma with fresh-frozen tumour tissues were collected, of which 10 (case 1 to 10) from the Department of Pathology, University of Cambridge, UK and 5 (cases 11 to 15) from the Department of Morphology and Molecular Pathology, University of Leuven, Belgium (Table 1). t(11;18)(q21;q21) and the API2-MALT1 fusion junction at the transcript level were identified previously (Table 1; [35], [36]; unpublished for cases 2, 4, 13-15). The breakpoint on the der(18) was identified previously for 9 cases (Table 1; [35], [36]). Two t(11;18)(q21;q21)-negative MALT lymphoma cases and control spleen and lymph node samples were retrieved from the Department of Morphology and Molecular Pathology, University of Leuven, Belgium. For western blot analysis, tumour tissues were lysed in 100 mM Tris-Cl pH 8.0, 300 mM NaCl, 0.04% NaN3, 0.2% SDS, 2% NP-40, 1% Na-deoxycholate, 2 mM EDTA, 100 mg/ml PMSF and 1 mg/ml leupeptin. RNA isolation and cDNA synthesis were performed as described ([30] for cases 1-10 and [35] for cases 11-14). BCL10 immunohistochemistry was performed as described [30].
###end p 76
###begin title 77
(Quantitative) RT-PCR and sequence analysis of MALT1-API2 transcripts
###end title 77
###begin p 78
###xml 87 97 87 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1-API2</italic>
###xml 211 216 211 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1</italic>
###xml 256 260 256 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">API2</italic>
###xml 338 343 338 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1</italic>
###xml 383 387 383 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">API2</italic>
###xml 398 404 398 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004822-g001">Fig 1B</xref>
###xml 450 455 450 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1</italic>
###xml 528 533 528 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1</italic>
###xml 555 563 555 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004822.s001">Fig S1AB</xref>
###xml 577 582 577 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1</italic>
###xml 616 621 616 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 710 716 710 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004822-g001">Fig 1B</xref>
###xml 1092 1097 1092 1097 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HPRT1</italic>
###xml 1111 1115 1111 1115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M8A8</italic>
###xml 1131 1135 1131 1135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A7M9</italic>
###xml 1163 1167 1163 1167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M4A8</italic>
###xml 1183 1187 1183 1187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A7M5</italic>
###xml 1242 1249 1242 1249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004822-t002">Table 2</xref>
To determine in our collection of t(11;18)(q21;q21)-positive MALT lymphoma samples the MALT1-API2 fusion variant at transcript level, two different RT-PCR reactions were performed: one with primers MALT1-F1 (in MALT1 exon 2) and API2-R1 (in RING domain of API2 exon 10), followed by a second round of nested PCR with primers MALT1-F2 (in MALT1 exon 2) and API2-R2 (in RING domain of API2 exon 10) (Fig 1B), and a second one with primers MALT1-F3 (in MALT1 exon 4) and API2-R1, followed by a nested PCR with primers MALT1-F4 (in MALT1 exon 4) and API2-R2 (Fig S1AB). RT-PCR for MALT1 (with MALT1-F5 and MALT1-R1) and GAPDH (with GAPDH-F and GAPDH-R) were performed to check for RNA quality. The PCR products in Fig 1B were sequenced using primers MALT1-F2 and API2-R2. Big Dye Terminator Cycle Sequencing Reactions were analyzed on an ABI PRISM 3130 Genetic Analyzer (Applied Biosystems, Lennik, Belgium). Quantitative RT-PCR was performed with the LightCycler 480 SYBR Green I master mix (Roche Diagnostics Belgium) and analyzed using the comparative dCt method to check expression levels of HPRT1 (HPRT1-F/R), M8A8 (M8A8-F/R) and A7M9 (A7M9-F/R) for case 11 and M4A8 (M4A8-F/R) and A7M5 (A7M5-F/R) for case 12. Primer sequences are shown in Table 2.
###end p 78
###begin title 79
Sequence of the primers used.
###end title 79
###begin title 80
Supporting Information
###end title 80
###begin p 81
###xml 19 29 19 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MALT1-API2</italic>
###xml 258 265 258 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004822-t001">Table 1</xref>
###xml 445 452 445 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004822-t002">Table 2</xref>
RT-PCR analysis of MALT1-API2 expression in t(11;18)(q21;q21)-positive MALT lymphoma. A, Shown are the amplification products of RT-PCR reactions with primers MALT1-F3 and API2-R1 on cDNA extracted from 14 t(11;18)(q21;q21)-positive MALT lymphoma cases (see Table 1). A PCR on pcD-F-M4A8 and pcD-F-M8A8 was performed as positive control. B, A second round of nested PCR was performed with primers MALT1-F4 and API2-R2. For primer sequences, see Table 2.
###end p 81
###begin p 82
(1.63 MB PDF)
###end p 82
###begin p 83
Click here for additional data file.
###end p 83
###begin p 84
We thank Dr. Martin Dyer, University of Leicester, United Kingdom for the SSK41 cells.
###end p 84
###begin title 85
References
###end title 85
###begin article-title 86
Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types.
###end article-title 86
###begin article-title 87
Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32).
###end article-title 87
###begin article-title 88
T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma.
###end article-title 88
###begin article-title 89
MALT1 is deregulated by both chromosomal translocation and amplification in B-cell non-Hodgkin lymphoma.
###end article-title 89
###begin article-title 90
The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas.
###end article-title 90
###begin article-title 91
The incidence and anatomic site specificity of chromosomal translocations in primary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) in North America.
###end article-title 91
###begin article-title 92
MALT lymphoma: from morphology to molecules.
###end article-title 92
###begin article-title 93
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human anti-apoptotic proteins cIAP1 and cIAP2 bind but do not inhibit caspases.
###end article-title 93
###begin article-title 94
The inhibitor of apoptosis, cIAP2, functions as a ubiquitin-protein ligase and promotes in vitro monoubiquitination of caspases 3 and 7.
###end article-title 94
###begin article-title 95
Cellular inhibitor of apoptosis 1 and 2 are ubiquitin ligases for the apoptosis inducer Smac/DIABLO.
###end article-title 95
###begin article-title 96
Differential requirement for Malt1 in T and B cell antigen receptor signaling.
###end article-title 96
###begin article-title 97
Regulation of NF-kappaB-dependent lymphocyte activation and development by paracaspase.
###end article-title 97
###begin article-title 98
Bcl10 is a positive regulator of antigen receptor-induced activation of NF-kappaB and neural tube closure.
###end article-title 98
###begin article-title 99
A requirement for CARMA1 in TCR-induced NF-kappa B activation.
###end article-title 99
###begin article-title 100
The molecular adapter Carma1 controls entry of IkappaB kinase into the central immune synapse.
###end article-title 100
###begin article-title 101
MALT1/paracaspase is a signaling component downstream of CARMA1 and mediates T cell receptor-induced NF-kappaB activation.
###end article-title 101
###begin article-title 102
Caspase-8 regulation by direct interaction with TRAF6 in T cell receptor-induced NF-kappaB activation.
###end article-title 102
###begin article-title 103
Malt1 ubiquitination triggers NF-kappaB signaling upon T-cell activation.
###end article-title 103
###begin article-title 104
NEMO recognition of ubiquitinated Bcl10 is required for T cell receptor-mediated NF-kappaB activation.
###end article-title 104
###begin article-title 105
Bcl10 activates the NF-kappaB pathway through ubiquitination of NEMO.
###end article-title 105
###begin article-title 106
Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma.
###end article-title 106
###begin article-title 107
Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappa B signaling pathway.
###end article-title 107
###begin article-title 108
Constitutive NF-kappaB activation by the t(11;18)(q21;q21) product in MALT lymphoma is linked to deregulated ubiquitin ligase activity.
###end article-title 108
###begin article-title 109
###xml 48 51 <span type="species:ncbi:8790">Emu</span>
###xml 63 67 <span type="species:ncbi:10090">mice</span>
Selective expansion of marginal zone B cells in Emu-API2-MALT1 mice is linked to enhanced IkappaB kinase gamma polyubiquitination.
###end article-title 109
###begin article-title 110
MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-kappa B-dependent proliferative advantage and resistance against FAS-induced cell death in B cells.
###end article-title 110
###begin article-title 111
A Novel TRAF6 binding site in MALT1 defines distinct mechanisms of NF-kappaB activation by API2-MALT1 fusions.
###end article-title 111
###begin article-title 112
Activation of NF-kappaB and inhibition of p53-mediated apoptosis by API2/mucosa-associated lymphoid tissue 1 fusions promote oncogenesis.
###end article-title 112
###begin article-title 113
Antiapoptotic function of apoptosis inhibitor 2-MALT1 fusion protein involved in t(11;18)(q21;q21) mucosa-associated lymphoid tissue lymphoma.
###end article-title 113
###begin article-title 114
cIAP2 is a ubiquitin protein ligase for BCL10 and is dysregulated in mucosa-associated lymphoid tissue lymphomas.
###end article-title 114
###begin article-title 115
T(11;18)(q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10.
###end article-title 115
###begin article-title 116
BCL10 mutation does not represent an important pathogenic mechanism in gastric MALT-type lymphoma, and the presence of the API2-MLT fusion is associated with aberrant nuclear BCL10 expression.
###end article-title 116
###begin article-title 117
A novel gene, MALT1 at 18q21, is involved in t(11;18) (q21;q21) found in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue.
###end article-title 117
###begin article-title 118
Heterogeneity of the API2-MALT1 gene rearrangement in MALT-type lymphoma.
###end article-title 118
###begin article-title 119
API2-MALT1 chimeric transcripts involved in mucosa-associated lymphoid tissue type lymphoma predict heterogeneous products.
###end article-title 119
###begin article-title 120
Structure of the MLT gene and molecular characterization of the genomic breakpoint junctions in the t(11;18)(q21;q21) of marginal zone B-cell lymphomas of MALT type.
###end article-title 120
###begin article-title 121
t(11;18)(q21;q21) of mucosa-associated lymphoid tissue lymphoma results from illegitimate non-homologous end joining following double strand breaks.
###end article-title 121
###begin article-title 122
API2-MALT1 fusion protein induces transcriptional activation of the API2 gene through NF-kappaB binding elements: evidence for a positive feed-back loop pathway resulting in unremitting NF-kappaB activation.
###end article-title 122
###begin article-title 123
###xml 108 123 <span type="species:ncbi:10090">transgenic mice</span>
Efficient biotinylation and single-step purification of tagged transcription factors in mammalian cells and transgenic mice.
###end article-title 123
###begin article-title 124
Smac/DIABLO selectively reduces the levels of c-IAP1 and c-IAP2 but not that of XIAP and livin in HeLa cells.
###end article-title 124
###begin article-title 125
Receptor interacting protein is ubiquitinated by cellular inhibitor of apoptosis proteins (c-IAP1 and c-IAP2) in vitro.
###end article-title 125
###begin article-title 126
Mass spectrometric analysis of tumor necrosis factor receptor-associated factor 1 ubiquitination mediated by cellular inhibitor of apoptosis 2.
###end article-title 126
###begin article-title 127
IAP Antagonists Induce Autoubiquitination of c-IAPs, NF-kappaB Activation, and TNFalpha-Dependent Apoptosis.
###end article-title 127
###begin article-title 128
Interchangeable binding of Bcl10 to TRAF2 and cIAPs regulates apoptosis signaling.
###end article-title 128
###begin p 129
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 129
###begin p 130
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: Supported by the Interuniversity Attraction Poles (IAP5/25), Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (G050704) and Catholic University Leuven (Concerted Action Grant to P.M.); and by the Leukemia Research Fund, United Kingdom (to M.Q.D.). H.N. is aspirant with the FWO-Vlaanderen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 130

